Cargando…
Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis
Tofacitinib was the first Janus kinase inhibitor to be approved for the treatment of rheumatoid arthritis (RA), and there is a large body of data to inform the efficacy and safety of this drug for patients at different places in their treatment journeys and with diverse demographics and characterist...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286162/ https://www.ncbi.nlm.nih.gov/pubmed/37360417 http://dx.doi.org/10.1177/20406223231178273 |